Sequence information
DRAVP ID DRAVPc046
Name Solnatide
Sequence
Molecular Formula Not Available
Condition/Disease COVID-19 caused Acute Lung Injury
Group Phase Ⅱ clinical trial
Type Peptide
Description Solnatide has been used in trials studying the treatment of Acute Lung Injury.
Active sequence/Structure
External Links
DrugBank Accession Number DB12136
Pubchem ID 91864495
CHEMBL ID CHEMBL4297885
UNII 17ZS80333G
CAS 259206-53-6
Reference 35379296
ClinicalTrails Information
| NCT Number | Study Title | Condition/Disease | Status | Phase | Sponsor |
|---|---|---|---|---|---|
| 2020-001244-26(EU) | COVID-19: Efficacy of solnatide to treat pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS - a pilot-trial. | COVID-19 | Prematurely Ended | Phase 2 |
